Phase I dose escalation study of oral lapatinib in combination with docetaxel in patients with HER2-positive locally advanced or metastatic breast cancer (LAMBC): Initial safety and tolerability results.
Pierre Fumoleau
No relevant relationships to disclose
Florence Dalenc
No relevant relationships to disclose
Audrey Mailliez
No relevant relationships to disclose
Corinne Veyret
No relevant relationships to disclose
Jacques Bonneterre
No relevant relationships to disclose
Cecile Guillemet
No relevant relationships to disclose
Sylvie Zanetta
No relevant relationships to disclose
Cristian Moldovan
No relevant relationships to disclose
Séverine Guiu
No relevant relationships to disclose
Jeremy Skrzypski
No relevant relationships to disclose
Mélanie Gauthier
No relevant relationships to disclose
Bruno P. Coudert
No relevant relationships to disclose
Nicolas Isambert
No relevant relationships to disclose